<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00742443</url>
  </required_header>
  <id_info>
    <org_study_id>RN1001-0091</org_study_id>
    <nct_id>NCT00742443</nct_id>
  </id_info>
  <brief_title>Juvista in Scar Revision Surgery of Disfiguring Scars</brief_title>
  <acronym>Revise</acronym>
  <official_title>A Double Blind, Within Patient, Placebo Controlled Trial to Assess the Efficacy of Juvista (Avotermin) in Conjunction With Scar Revision Surgery for the Improvement of Disfiguring Scars.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renovo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Renovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is to determine whether Juvista can prevent scar formation or improve the
      appearance of scars following scar revision surgery. The trial will involve comparing Juvista
      to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each year, over one hundred million people undergo elective or emergency surgery and are left
      with scarring. Of these, over half a million patients undergo scar revision surgery. These
      types of scars are usually disfiguring, aesthetically unpleasant and can cause complications
      such as severe itching, tenderness, pain, depression and disruption of daily activities which
      can lead to a diminished quality of life. There is a clinical need for treatments that reduce
      scarring, as current therapies are often ineffective or inadequate.

      Results from previous clinical trials show that Juvista is effective in improving scars in
      young and elderly males and females. Juvista-treated wounds appear to heal with scars that
      are more similar to the surrounding skin, and are narrower and paler with a faster fading of
      redness compared to placebo and standard care alone. This study will confirm the
      effectiveness of Juvista (avotermin) in the improvement of scar appearance when applied to
      the wound margins of patients following scar revision surgery of disfiguring scars.

      The study is a double blind, within patient, placebo controlled, randomised trial in male and
      female patients. Patients will be asked to attend 10 study visits and will be followed up
      post-surgery for 12 months.

      The potential benefits to the patients taking part in the trial will be that their scar is
      revised by a plastic surgeon. This procedure should leave subjects with a less noticeable
      scar. The existing scar will be surgically removed and the resulting wound will be divided
      into two segments of equal length. In most patients, one segment will receive treatment with
      Juvista administered by intradermal injection, the other with placebo. A few patients will
      receive treatment with Juvista to both segments of the wound.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global Scar Comparison Scale as assessed by an Independent Clinical Scar Assessment Panel using photographs of the treated scars.</measure>
    <time_frame>12 months post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Scar Comparison Scale assessed by the patient looking at their own scars.</measure>
    <time_frame>12 months post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Cicatrix</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active versus Placebo within patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active vs. Placebo within patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active vs. Active within patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Juvista (avotermin)</intervention_name>
    <description>100ng/100µL Juvista administered to each linear centimetre of the margins of one wound segment by intradermal injection immediately after and then 24h after wound closure versus 100μL of placebo administered to each linear centimetre of the margins of the other wound segment by intradermal injection immediately after and then 24h after wound closure</description>
    <arm_group_label>1</arm_group_label>
    <other_name>RN1001, TGFβ3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Juvista (avotermin)</intervention_name>
    <description>250ng/100µL Juvista administered to each linear centimetre of the margins of one wound segment by intradermal injection immediately after and then 24h after wound closure versus 100μL of placebo administered to each linear centimetre of the margins of the other wound segment by intradermal injection immediately after and then 24h after wound closure</description>
    <arm_group_label>2</arm_group_label>
    <other_name>RN1001, TGFβ3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Juvista (avotermin)</intervention_name>
    <description>250ng/100µL Juvista administered to each linear centimetre of the margins of both wound segments by intradermal injection immediately after and then 24h after wound closure</description>
    <arm_group_label>3</arm_group_label>
    <other_name>RN1001, TGFβ3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-85 years who have provided written informed consent.

          -  BMI between 15 and 35 kg/m2

          -  Patients with, in the opinion of the Investigator, clinically acceptable results for
             the laboratory tests specified in the trial protocol.

          -  If females of child bearing potential, patients must be using a highly effective
             method(s) of contraception and agree to do so from at least the screening visit until
             one month after administration of the final study dose.

          -  The scar area to be revised is disfiguring. To be considered disfiguring for this
             trial scars must have at least one of the following characteristics.

          -  Scar area 13 or more cm in length.

          -  Scar area at least 0.6 cm wide at widest part.

          -  Surface contour of scar area elevated or depressed on palpation.

          -  Scar area adherent to underlying tissue.

          -  Skin hypo-or hyper-pigmented in an area exceeding 39cm2.

          -  Skin texture abnormal (irregular, atrophic, shiny, scaly, etc.) in an area exceeding
             39cm2.

          -  The scar to be revised is at least 12 months old.

          -  The investigator considers that the appearance of the scar area to be revised can be
             improved with surgery alone.

          -  The scar area is linear and suitable for revision by excision and direct closure.

          -  The scar area to be revised is symmetrical in appearance around the mid-line.

          -  The scar area to be revised is between 7 and 20cm in length.

          -  The scar area to be revised runs along a flat surface which is in the same focal plane
             and suitable for accurate medical photography.

          -  The scar is approved for entry into the trial by the Independent Expert Screening
             Panel.

        Exclusion Criteria

          -  Patients who on direct questioning and / or physical examination, have evidence of any
             past or present clinically significant medical condition that would impair wound
             healing.

          -  Patients with a creatinine clearance (CLcr) of 80ml/min or less. Creatinine clearance
             will be determined from the serum creatinine level at pre-study screening using the
             following formula :

          -  CLcr = (140-age (years)) x weight(kg)/ 72 x serum creatinine (mg/dL) {x 0.85 for
             females}

          -  Patients with a skin disorder that is chronic or currently active.

          -  Patients who, in the opinion of the Investigator, have significant ongoing psychiatric
             disorders, which may interfere with the trial assessments / visits.

          -  Patients with a history of clinically significant hypersensitivity to any of the drugs
             or surgical dressings to be used in this trial.

          -  Patients who are taking, or have taken, any investigational drugs within 3 months
             prior to the screening visit.

          -  Patients undergoing investigations or changes in management for an existing medical
             condition (excluding the scar for revision).

          -  Patients who are or who become pregnant up to and including Day 0 or who are
             lactating.

          -  In the opinion of the Investigator, a patient who is not likely to complete the trial.

          -  Patients who on direct questioning and physical examination have history or evidence
             of keloid scarring.

          -  Patients with scar areas for revision that cross a joint or are in close proximity to
             an anatomical structure, which could lead to distortion of the resultant scar or
             difficulty in taking photographs.

          -  Patients with additional scars less than 3cm away from the area to be revised.

          -  Patients with scars that require revision using Z-plasty, W-plasty or any other such
             techniques.

          -  Patients who are involved in ongoing litigation in connection with the scar to be
             revised.

          -  Patients who have had surgery in the area to be excised within one year of Day 0.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D A McGrouther, FRCS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BodyAesthetic Research Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grymer Privathospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense Universitetshopital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sollorod Privethospital, Primary Clinic, Hjortholmsvej 2C</name>
      <address>
        <city>Viruni</city>
        <zip>2830</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital maternité de Metz</name>
      <address>
        <city>Metz</city>
        <zip>57045</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Lapeyronie</name>
      <address>
        <city>Montpelliers</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Emile Muller, Service de chirurgie plastique</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin Luther Krankenhaus</name>
      <address>
        <city>Berlin</city>
        <zip>14193</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin, Zentrum für Schwerbrandverletzte mit Plastischer Chirurgie, Warener Strasse 7</name>
      <address>
        <city>Berlin</city>
        <zip>D-12683</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BG-Universitätsklinik Bergmannsheil GmbH</name>
      <address>
        <city>Bochum</city>
        <zip>D-44789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Josef und St Elisabeth Hospital, Klinik fur Dermatologie und Allergologie, Gundrunstrasse 56</name>
      <address>
        <city>Bochum</city>
        <zip>D-44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Friedrich-Schiller-Universität Jena, Klinik für Dermatologie, Erfurter Strasse 35</name>
      <address>
        <city>Jena</city>
        <zip>D-07740</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotes-Kreuz-Krankenhaus Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>D-34121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein- Campus Lübec Plastische Chirurgie, Handchirurgie, Ratzeburger Allee 160</name>
      <address>
        <city>Lubeck</city>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BG - Unfallklinik Ludwigshafen</name>
      <address>
        <city>Ludwigshafen am Main</city>
        <zip>D-67071</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Offenbach GmbH - Chirurgische Klinik III, Starkenburgring 66</name>
      <address>
        <city>Offenbach</city>
        <zip>D-63069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Brüder Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>D-93049</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fővárosi Önkormányzat Egyesített Szent István és Szent László Kórház-Rendelőintézet</name>
      <address>
        <city>Budapest</city>
        <zip>1097</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HM Állami Egészségügyi Központ</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Magyarországi Református Egyház Bethesda Gyermekkórháza Égéssérült Gyermekeket Ellátó Országos Központ</name>
      <address>
        <city>Budapest</city>
        <zip>1146</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kenézy Kórház Rendelőintézet Egészségügyi Szolgáltató Kft.</name>
      <address>
        <city>Debrecen</city>
        <zip>4043</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miskolci Egészségügyi Központ</name>
      <address>
        <city>Miskolc</city>
        <zip>3529</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università degli studi di Genova</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgia Plastica e Ricostruttiva, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione S. Maugeri, U.O. DI CHIRURGIA PLASTICA E RICOSTRUTTIVA</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgia Plastica, Umberto I Policlinico di Roma</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Circolo di Varese &quot;Fondazione Macchi&quot;, Chirurgia Plastica</name>
      <address>
        <city>Varese</city>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paula Stradina Clinical University Hospital</name>
      <address>
        <city>Riga</city>
        <zip>LV-1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>110 Szpital Wojskowy z Przychodnia</name>
      <address>
        <city>Elblag</city>
        <zip>82307</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinkia Chirurgii Plastycznej, Akademickie Centrum Kliniczne</name>
      <address>
        <city>Gdansk</city>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej Zachodniopomorski</name>
      <address>
        <city>Gryfice</city>
        <zip>72-300</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Szpital Specjalistyczny im. Ludwika Rydygiera, os. Złotej Jesieni 1</name>
      <address>
        <city>Krakow</city>
        <zip>31-826</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojskowy Instytut Medyczny Kliniczny Oddział Chirurgii Plastycznej,</name>
      <address>
        <city>Warsaw</city>
        <zip>00909</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Señora del Perpetuo Socorro</name>
      <address>
        <city>Albacete</city>
        <zip>02006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau, Departamento Cirugía Plástica</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic, Departament o Cirugia plástica</name>
      <address>
        <city>Barcelona</city>
        <zip>8036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ibermutuamur</name>
      <address>
        <city>Madrid</city>
        <zip>28043</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Conxo-Complejo Hospitalario Universitario de Santiago de Compostela, Servicio de Cirugía plástica</name>
      <address>
        <city>Santiago de Compostela</city>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Victoria Hospital (QVH) NHS Foundation Trust</name>
      <address>
        <city>East Grinstead</city>
        <state>West Sussex</state>
        <zip>RH19 3DZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Selly Oak Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B29 6JD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Plastic Surgery</name>
      <address>
        <city>Bristol</city>
        <zip>BS1 4LF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nuffield Health Bristol Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS8 1JU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renovo Clinical Trials Unit, 48 Grafton Street</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Latvia</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2008</study_first_submitted>
  <study_first_submitted_qc>August 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2008</study_first_posted>
  <last_update_submitted>March 2, 2011</last_update_submitted>
  <last_update_submitted_qc>March 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>Julia Cook (Clinical Trial Manager)</name_title>
    <organization>Renovo</organization>
  </responsible_party>
  <keyword>Scar Revision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

